Адильгереева Эльмира Пайзутдиновна
29 works · 92 citations · h-index 5
Top works
- Frequent variations in cancer-related genes may play prognostic role in treatment of patients with chronic myeloid leukemia
- Whole-exome sequencing reveals potential molecular predictors of relapse after discontinuation of the targeted therapy in chronic myeloid leukemia patients
- P.F508del editing in cells from cystic fibrosis patients
- Generation of induced pluripotent stem cell line (RCMGi001-A) from human skin fibroblasts of a cystic fibrosis patient with p.F508del mutation
- Copy number variation analysis in cytochromes and glutathione S-transferases may predict efficacy of tyrosine kinase inhibitors in chronic myeloid leukemia
- Experimental approaches to the target editing of the CFTR gene using CRISPR-Cas9
- Экспериментальные подходы к таргетному редактированию гена CFTR с помощью CRISPR-Cas9
- Exome, transcriptome and miRNA analysis don’t reveal any molecular markers of TKI efficacy in primary CML patients
- Cultivation and Differentiation Change Nuclear Localization of Chromosome Centromeres in Human Mesenchymal Stem Cells
- Genetic markers of stable molecular remission in chronic myeloid leukemia after targeted therapy discontinuation
- ePS1.01 F508del correction in iPSCs obtained from patient with cystic fibrosis by CRISPR/Cas9
- Получение индуцированных плюрипотентных стволовых клеток из фибробластов пациента с муковисцидозом
- Copy Number Variations in Cytochromes and Glutathione-Transferases As Early Predictors of the Efficacy of Tyrosine Kinase Inhibitors in CML
- Анализ транскриптома опухолевых клеток при хроническом миелоидном лейкозе
- WS09.3 Development of effective method for F508del mutation correction using CRISPR/Cas9
- Экзомное секвенирование и поиск предикторов эффективности терапии лейкозов
- RECEIVING INDUCED PLURIPOTENTIAL STEM CELLS FROM FIBROBLASTS OF PATIENTS WITH CYSTIC FIBROSIS
- Variants in the ASXL1 and DMNT3A genes are potential markers of the effectiveness of tyrosine kinase inhibitors therapy in chronic myeloid leukemia
- Факторы, влияющие на эффективность CRISPR/Cas9 для коррекции мутации F508del при муковисцидозе
- Варианты в генах ASXL1 и DMNT3A - потенциальные маркеры эффективности терапии ингибиторами тирозинкиназ при хроническом миелоидной лейкозе